ETF1P3

Across TCGA pan-cancer cohorts, ETF1P3 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated ETF1P3 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher ETF1P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ETF1P3 expression acts as an unfavorable survival marker, although some lineages such as ESCA and GBM show a favorable association.

CESC, LUSC, and LUAD are the cancer types where ETF1P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Tertile	IV	0.208	0.670	.001	68	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
LUAD	DFS	Tertile	III,IV	0.428	0.670	.013	36	view →
ESCA	OS	Tertile	III,IV	0.702	0.312	<.001	31	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	27	view →
KIRC	DFS	Quartile	IV	0.167	0.383	.007	25	view →
UVM	DFS	Tertile	All	0.405	0.761	.044	18	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
PCPG	DFS	Tertile	All	0.111	0.869	.001	18	view →
SKCM	OS	Tertile	IV	0.509	0.795	.007	18	view →
THCA	OS	Tertile	III,IV	0.494	0.931	.003	15	view →
KIRP	DFS	Tertile	III,IV	0.418	0.737	.033	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

ETF1P3–CESC (DFS)

Open the CESC breakdown →